410 Medical is dedicated to developing innovative products that help emergency clinicians provide better care for critically ill patients.

AtaCor Medical is developing a novel extracardiac pacing system that does not require leads or hardware to be placed inside or onto the heart.

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

Boomerang Medical is developing a technology to advance the treatment of autoimmune diseases by using electrical nerve stimulation

Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI

Contego Medical has developed a platform based on the integration of an embolic protection filter and a treatment device into one single catheter.

CVRx has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. IPO in June 2021 (NASDAQ: CVRX).

Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021

Developer of a system to enhance embolic cerebral protection. Acquired by Edwards Lifesciences (NYSE: EW) in March 2011.

Endogenex is a clinical stage company, founded to improve outcomes for people living with Type 2 Diabetes.

Developer of biologic and medical device technologies for wound management designed to improve the safety and availability of human blood supply.

Provider of a histotripsy platform designed for the treatment of cancer. Acquired by Bezos Expeditions, Wellington K5 Global 2025

iVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke.

Standard Bariatrics is developing a clamp and stapler to standardize sleeve gastrectomy procedures. Acquired by Teleflex in September 2022.

Synaptrix is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management.

Sleep management platform built to address sleep conditions from testing through ongoing care via a wearable patch
